Squarepoint’s Sanara MedTech SMTI Stock Holding History
Bought
Maintained
Sold
Other funds holding SMTI
SWM
Squarepoint's SMTI Position: Q2 2026 in Review
Squarepoint reduced its Sanara MedTech (SMTI) stake by 27% in Q2 2026, selling an estimated $409K and leaving 53,811 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2712.
Squarepoint first reported a position in SMTI in Q3 2024 and has held it in 8 quarters since. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.
- Squarepoint held 53,811 shares of Sanara MedTech worth $1.27M as of Q2 2026.
- Squarepoint sold 19,796 Sanara MedTech shares in Q2 2026, an estimated $409K.
- Sanara MedTech made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2712 holding.
- Squarepoint first reported a position in Sanara MedTech in Q3 2024 and has held it in 8 quarters since.
- 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.